Case Report: First In-Human Report of Cure of Refractory Mycoplasma genitalium Infection With Omadacycline

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Mycoplasma genitalium (MG) is a significant cause of sexually transmitted nongonococcal urogenital infections.
• High rates of antimicrobial resistance in MG limit treatment options.
• Management guidelines for refractory MG infections are lacking.

Purpose of the Study:

• To describe the first in-human case of refractory Mycoplasma genitalium infection treated successfully with omadacycline.
• To highlight omadacycline as a potential therapeutic option for multidrug-resistant MG infections.

Main Methods:

• Case report of a patient with refractory Mycoplasma genitalium infection.
• Treatment administered: omadacycline.
• Outcome assessment: clinical cure of infection.

Main Results:

• The patient with refractory Mycoplasma genitalium infection achieved a clinical cure after treatment with omadacycline.
• This represents the first documented human case of successful MG treatment with omadacycline.

Conclusions:

• Omadacycline shows promise as a treatment for refractory and multidrug-resistant Mycoplasma genitalium infections.
• Further research is warranted to evaluate omadacycline's efficacy and safety in a larger cohort.